Published in AIDS Weekly, February 13th, 1995
The data were presented at the 2nd National Conference on Human Retroviruses and Related Infections, held in Washington, D.C., January 29-February 2, 1995.
The SCID-hu mouse model is used by the U.S. National Institute of Allergy and Infectious Diseases to evaluate compounds exhibiting promising in vitro results against HIV-1. SCID-hu mice are immunodeficient mice that are transplanted with human fetal liver and thymus tissue. HIV-1 is injected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.